PF-5901

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePF-5901
Drug Alias NamePF-5901RG-5901REV-5901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene B4 receptor antagonistsCysteinyl leukotriene receptor 1 antagonistsArachidonate 5-lipoxygenase inhibitors
TargetsLeukotriene B4 receptorCysteinyl leukotriene receptor 1Arachidonate 5-lipoxygenase
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPurdue Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPurdue Pharma
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A